Health Articles

RSS

What Is Culinary Medicine? Bridging Nutrition, Cooking, and Health

Culinary medicine combines nutrition science with practical cooking education to help patients apply dietary advice and train healthcare professionals in nutrition counseling. Studies report improvements in cooking confidence and dietary behaviors, but evidence for sustained clinical benefits remains limited.

20 Oct 2026

How Non-Alcoholic Drinks Affect the Brain: Reward, Rituals, and Expectations

Flavor cues, drinking rituals, and learned expectations can shape brain activity, perceived intoxication, and alcohol craving without substantial alcohol exposure. Research on alcohol-free alternatives remains limited, particularly regarding long-term alcohol reduction and outcomes in people with alcohol use disorder.

20 Oct 2026

What Are Ancient Grains, and How Can They Improve Your Diet?

Ancient and underutilized crops can broaden modern diets by providing fiber, protein, micronutrients, and bioactive compounds. Their nutritional and environmental value varies with the crop, preparation, and growing conditions, while evidence for long-term clinical benefits remains limited.

19 Oct 2026

How Indoor Living May Be Changing the Human Microbiome

Indoor environments contain distinct microbial communities shaped by building design, ventilation, human activity, and contact with outdoor environments. Research suggests these exposures may influence the human microbiome and immune development, but their direct effects on health remain uncertain, highlighting the need to balance microbial contact with effective hygiene.

13 Oct 2026

Maqui Berry: Health Benefits, Nutrition, and Uses

Maqui berries contain anthocyanins and other polyphenols studied for their antioxidant activity and effects on inflammation, glucose regulation, and eye health. Human trials suggest possible benefits for postprandial blood glucose and dry-eye symptoms, but evidence for healthy aging and long-term safety remains limited.

23 Oct 2026

Jaboticaba Fruit: What Are Its Potential Health Benefits?

Jaboticaba contains polyphenols and dietary fiber that researchers are studying for their effects on oxidative stress, gut microbiota, and metabolic health. Small human trials suggest improvements in selected glucose and inflammatory markers, but most evidence remains preclinical, and effective doses and long-term safety require further study.

22 Oct 2026

What Is Inflammaging? Causes, Health Effects, and Ways to Reduce Inflammation

Inflammaging is a state of persistent, low-grade inflammation associated with aging, influenced by immune dysfunction, cellular senescence, oxidative stress, and changes in the gut microbiome. This article examines how inflammaging contributes to age-related diseases, including cardiovascular disease, diabetes, and neurodegeneration, while exploring the potential of lifestyle interventions and emerging therapies to regulate chronic inflammation and support healthy aging.

22 Oct 2026

Gut Microbiome and Aging: How Gut Bacteria Influence Health and Longevity

The gut microbiome changes with age, with microbial diversity and function varying according to health status, diet, lifestyle, and medication use. These changes are associated with inflammation and age-related diseases, but evidence that microbiome-targeted interventions extend human lifespan remains limited.

19 Oct 2026

How GLP-1 Drugs Affect the Brain Beyond Weight Loss

Growing evidence suggests that GLP-1 drugs may influence mood, reward processing, cognition, reproductive health, and neurodegenerative diseases.

22 Oct 2026

How GLP-1 Drugs May Help Psoriasis and Hidradenitis Suppurativa

GLP-1 receptor agonists are increasingly being studied for potential dermatologic applications due to their anti-inflammatory effects.

22 Oct 2026

How GLP-1 Drugs Affect Cancer Risk: Evidence, Mechanisms, and Safety

GLP-1 receptor agonists are associated with lower rates of some cancers in observational studies, but randomized trials have not established cancer prevention or improved survival after diagnosis. Possible effects beyond weight loss remain under investigation, while thyroid and colorectal cancer signals require further study.

21 Oct 2026

Can GLP-1 Drugs Help Treat Osteoarthritis and Relieve Joint Pain?

GLP-1 receptor agonists may improve knee osteoarthritis symptoms through weight loss, while laboratory studies suggest additional anti-inflammatory and cartilage-protective effects. Clinical findings vary between drugs, and randomized trials have yet to establish whether these therapies slow structural joint damage.

21 Oct 2026

How GLP-1 Medications Affect PCOS, Fertility, and Pregnancy

GLP-1 receptor agonists improve weight and insulin resistance in women with PCOS, with preliminary studies suggesting benefits for ovulation and conception. Their direct effects on fertility remain uncertain, and limited pregnancy safety data require careful contraceptive and preconception planning.

20 Oct 2026

GLP-1 Drugs and Obstructive Sleep Apnea: How Weight Loss Medications Improve Breathing During Sleep

Incretin-based therapies, particularly tirzepatide and liraglutide, can reduce obstructive sleep apnea severity in adults with obesity while improving weight and some cardiometabolic risk factors. Evidence remains limited regarding benefits after treatment discontinuation, effects in other patient populations, and prevention of cardiovascular events.

19 Oct 2026

GLP-1 Drugs and Mental Health: Effects on Depression and Anxiety

GLP-1 receptor agonists affect pathways involved in mood, appetite, and reward, prompting research into their potential benefits for depression, substance use disorders, and binge eating. Psychiatric treatment benefits remain unproven, while conflicting observational findings and reassuring trial evidence require careful interpretation.

20 Oct 2026

How GLP-1 Drugs May Help Treat Addiction: Mechanisms and Clinical Evidence

GLP-1 receptor agonists influence brain pathways involved in reward and craving, prompting research into their potential use for alcohol, nicotine, and other substance use disorders. Animal findings and some early human trials suggest benefits, but mixed clinical results and limited long-term evidence leave their effectiveness in addiction treatment uncertain.

18 Oct 2026

Can GLP-1 Drugs Treat Parkinson’s Disease? What Research Shows

GLP-1 receptor agonists affect metabolic, inflammatory, and neuronal survival pathways implicated in Parkinson’s disease, with neuroprotective effects demonstrated in experimental models. Clinical trials have produced mixed findings, leaving disease-modifying benefits unproven and highlighting concerns about gastrointestinal side effects and weight loss.

16 Oct 2026

Cannabis and Health: How Cannabinoids Affect the Human Body

Dietary cannabinoids such as CBD show anti-inflammatory and immunomodulatory activity in experimental studies, but evidence that supplementation improves human health remains limited.

16 Oct 2026

How Poorly Maintained Hot Tubs Promote Legionella Growth

Poorly maintained hot tubs can support Legionella growth and release contaminated droplets that cause Legionnaires’ disease or Pontiac fever when inhaled. Appropriate disinfection, cleaning, water management, and routine monitoring reduce this risk, particularly for older adults and people with weakened immune defenses.

16 Oct 2026

Leech Therapy: How It Works and Its Uses in Modern Medicine

Medicinal leech saliva contains anticoagulant, antiplatelet, anti-inflammatory, and antimicrobial compounds that are attracting scientific interest as potential drug candidates. Research into these molecules has contributed to the development of direct thrombin inhibitors, while ongoing studies are investigating their potential applications in treating inflammation, infection, and other medical conditions.

13 Oct 2026